C12N 2720/12122
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2720/12122 (New viral proteins or individual genes, new structural or functional aspects of) appears on 10 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 10
- Published applications
- 7
- Assignees
- 10
- Inventors
- 16
- Latest grant
- 21 Dec 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 1 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Virus-enabled targeted vector for imaging21 Dec 2021US 11,202,841 B2The Trustees of Indiana University
- Vaccine against african horse sickness virus1 May 2012US 8,168,200 B2Merial Limited
- Recombinant vaccine against bluetongue virus4 Jan 2011US 7,862,821 B2Merial Limited
- Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system6 Apr 1999US 5,891,676 ABaylor College of Medicine
- Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system1 Dec 1998US 5,843,733 ABaylor College of Medicine
- Mrna recombinant capping enzymes16 Jul 2026US 2026/0201350 A1Sanofi Pasteur Limited
- Virus-enabled targeted vector for imaging20 Feb 2020US 2020/0054769 A1The Trustees of Indiana University
- Vaccine Against African Horse Sickness Virus1 May 2014US 2014/0120133 A1Merial Limited
- Vaccine against african horse sickness virus10 May 2012US 2012/0114691 A1
- Inactivated Live-Attenuated Bluetongue Virus Vaccine21 Apr 2011US 2011/0091500 A1Onderstepoort Biological Products Ltd.
Most cited
By later US patents
- Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system81US 5,891,676 ABaylor College of Medicine · 1999
- Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system78US 5,843,733 ABaylor College of Medicine · 1998
- Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system18US 5,186,933 ABaylor College of Medicine · 1993
- Multiple particulate antigen delivery system6US 5,667,782 AOxford University · 1997
- Production of antigens by self-assembly of polypeptide components3US 5,686,270 ANatural Environmental Research Council · 1997